ES2177373B1 - Preparacion de azitromicina en su forma no cristalina - Google Patents

Preparacion de azitromicina en su forma no cristalina

Info

Publication number
ES2177373B1
ES2177373B1 ES009902620A ES9902620A ES2177373B1 ES 2177373 B1 ES2177373 B1 ES 2177373B1 ES 009902620 A ES009902620 A ES 009902620A ES 9902620 A ES9902620 A ES 9902620A ES 2177373 B1 ES2177373 B1 ES 2177373B1
Authority
ES
Spain
Prior art keywords
azithromycin
preparation
crystalline form
invention describes
lyophilization
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES009902620A
Other languages
English (en)
Spanish (es)
Other versions
ES2177373A1 (es
Inventor
Jasanada Miguel Santos Bayod
Garcia Isidro Llorente
Mari Felix Fernandez
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AsturPharma SA
Original Assignee
AsturPharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AsturPharma SA filed Critical AsturPharma SA
Priority to ES009902620A priority Critical patent/ES2177373B1/es
Priority to EP01204550A priority patent/EP1234833B1/en
Priority to EP00500028A priority patent/EP1103558B1/en
Priority to DE60003509T priority patent/DE60003509T2/de
Priority to DE60027919T priority patent/DE60027919D1/de
Priority to AT00500028T priority patent/ATE243704T1/de
Priority to AT01204550T priority patent/ATE325805T1/de
Priority to US09/718,833 priority patent/US6451990B1/en
Priority to TR2000/03474A priority patent/TR200003474A3/tr
Priority to PL344101A priority patent/PL195910B1/pl
Priority to CA002485433A priority patent/CA2485433C/en
Priority to CA002326930A priority patent/CA2326930C/en
Priority to JP2000359948A priority patent/JP4260354B2/ja
Priority to ES200202318A priority patent/ES2207403B1/es
Publication of ES2177373A1 publication Critical patent/ES2177373A1/es
Application granted granted Critical
Publication of ES2177373B1 publication Critical patent/ES2177373B1/es
Priority to JP2008217072A priority patent/JP2009007376A/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES009902620A 1999-11-26 1999-11-26 Preparacion de azitromicina en su forma no cristalina Expired - Fee Related ES2177373B1 (es)

Priority Applications (15)

Application Number Priority Date Filing Date Title
ES009902620A ES2177373B1 (es) 1999-11-26 1999-11-26 Preparacion de azitromicina en su forma no cristalina
EP01204550A EP1234833B1 (en) 1999-11-26 2000-02-23 Preparation of crystalline azithromycin dihydrate.
EP00500028A EP1103558B1 (en) 1999-11-26 2000-02-23 Preparation of non-crystalline and crystalline dihydrate forms of azithromycin
DE60003509T DE60003509T2 (de) 1999-11-26 2000-02-23 Herstellung von nicht-kristallinen und kristallinen Dihydratformen von Azithromycin
DE60027919T DE60027919D1 (de) 1999-11-26 2000-02-23 Herstellung von kristalliner Dihydratform von Azithromycin
AT00500028T ATE243704T1 (de) 1999-11-26 2000-02-23 Herstellung von nicht-kristallinen und kristallinen dihydratformen von azithromycin
AT01204550T ATE325805T1 (de) 1999-11-26 2000-02-23 Herstellung von kristalliner dihydratform von azithromycin
US09/718,833 US6451990B1 (en) 1999-11-26 2000-11-22 Azithromycin preparation in its noncryst alline and crystalline dihydrate forms
TR2000/03474A TR200003474A3 (tr) 1999-11-26 2000-11-23 Azitromisinin kristalli olmayan ve kristalli dihitrat formlarinin hazirlanmasi
PL344101A PL195910B1 (pl) 1999-11-26 2000-11-24 Sposób wytwarzania 9-deokso-9a-aza-9a-metylo-9a-homoerytromycyny A w formie niekrystalicznej
CA002485433A CA2485433C (en) 1999-11-26 2000-11-24 Preparation of non-crystalline and crystalline dihydrate forms of azithromycin
CA002326930A CA2326930C (en) 1999-11-26 2000-11-24 Preparation of non-crystalline and crystalline dihydrate forms of azithromycin
JP2000359948A JP4260354B2 (ja) 1999-11-26 2000-11-27 非結晶および結晶二水和物形態のアジスロマイシンの調製
ES200202318A ES2207403B1 (es) 1999-11-26 2002-10-09 Preparacion de azitromicina en su forma dihidrato cristalina.
JP2008217072A JP2009007376A (ja) 1999-11-26 2008-08-26 非結晶および結晶二水和物形態のアジスロマイシンの調製

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES009902620A ES2177373B1 (es) 1999-11-26 1999-11-26 Preparacion de azitromicina en su forma no cristalina

Publications (2)

Publication Number Publication Date
ES2177373A1 ES2177373A1 (es) 2002-12-01
ES2177373B1 true ES2177373B1 (es) 2003-11-01

Family

ID=8310747

Family Applications (2)

Application Number Title Priority Date Filing Date
ES009902620A Expired - Fee Related ES2177373B1 (es) 1999-11-26 1999-11-26 Preparacion de azitromicina en su forma no cristalina
ES200202318A Expired - Fee Related ES2207403B1 (es) 1999-11-26 2002-10-09 Preparacion de azitromicina en su forma dihidrato cristalina.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES200202318A Expired - Fee Related ES2207403B1 (es) 1999-11-26 2002-10-09 Preparacion de azitromicina en su forma dihidrato cristalina.

Country Status (9)

Country Link
US (1) US6451990B1 (https=)
EP (2) EP1103558B1 (https=)
JP (2) JP4260354B2 (https=)
AT (2) ATE325805T1 (https=)
CA (1) CA2326930C (https=)
DE (2) DE60003509T2 (https=)
ES (2) ES2177373B1 (https=)
PL (1) PL195910B1 (https=)
TR (1) TR200003474A3 (https=)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20020231A2 (en) * 2002-03-18 2003-12-31 Pliva D D ISOSTRUCTURAL PSEUDOPOLYMORPHS OF 9-DEOXO-9a-AZA-9a-METHYL-9a-HOMOERYTHROMYCIN A
CA2245398C (en) 1998-08-21 2002-01-29 Apotex Inc. Azithromycin monohydrate isopropanol clathrate and methods for the manufacture thereof
ES2162764B1 (es) * 2000-05-17 2003-04-01 Ercros Ind Sa Forma polimorfica del dihidrato de azitromicina, y su procedimiento deobtencion.
HRP20030430B1 (hr) * 2000-11-27 2011-11-30 Biochemie S.A. Makrolidni solvati
IN190080B (https=) * 2001-01-29 2003-06-07 Alembic Ltd
KR100491183B1 (ko) * 2001-03-21 2005-05-25 한미약품 주식회사 아지트로마이신의 제조방법 및 이 방법에 사용되는9-데옥소-9에이-아자-9에이-호모에리트로마이신 에이의결정성 수화물
SI1390377T1 (sl) * 2001-05-22 2006-06-30 Pfizer Prod Inc Nova kristalna oblika azitromicina
ES2258142T3 (es) 2001-05-22 2006-08-16 Pfizer Products Inc. Nueva forma cristalina.
US6861413B2 (en) 2001-05-22 2005-03-01 Pfizer Inc. Stable non-dihydrate azithromycin oral suspensions
PL371259A1 (pl) 2001-12-21 2005-06-13 Pfizer Products Inc. Bezpośrednio sprasowywalne preparaty azytromycyny
MXPA04007847A (es) 2002-02-13 2005-02-24 Biogal Gyogyszergyar Metodo para extraer un macrolido de biomateria.
US7452692B2 (en) 2002-02-13 2008-11-18 Teva Gyógyszergyár Zártkörüen Müködö Részvénytársaság Method for extracting a macrolide from biomatter
HRP20020614A2 (en) 2002-07-22 2004-06-30 PLIVA-ISTRAŽIVAČKI INSTITUT d.o.o. Rhombic pseudopolymorph of 9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin a
WO2004089958A2 (en) * 2003-03-31 2004-10-21 TEVA Gyógyszergyár Részvénytársaság Crystallization and purification of macrolides
PL1558622T3 (pl) 2003-07-24 2008-06-30 Teva Gyogyszergyar Zartkoerueen Muekoedoe Reszvenytarsasag Sposób oczyszczania makrolidów
KR100844628B1 (ko) * 2003-12-04 2008-07-07 화이자 프로덕츠 인크. 제약상 다입자의 제조 방법
US7384921B2 (en) * 2004-02-20 2008-06-10 Enanta Pharmaceuticals, Inc. Polymorphic forms of 6-11 bicyclic ketolide derivatives
US7468428B2 (en) 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation
US20060116336A1 (en) * 2004-03-17 2006-06-01 American Pharmaceutical Partners, Inc. Lyophilized azithromycin formulation
WO2006115494A1 (en) * 2005-04-26 2006-11-02 American Pharmaceutical Partners, Inc. Lyophilized azithromycin formulation
US7683162B2 (en) 2004-08-30 2010-03-23 Taro Pharmaceutical Industries Limited Process of preparing a crystalline azithromycin monohydrate
US7464012B2 (en) * 2004-12-10 2008-12-09 L'air Liquide, Societe Anonyme A Directoire Et Conseil De Surveillance Pour L'etude Et L'exploitation Des Procedes Georges Claude Simplified process simulator
US7582312B2 (en) * 2004-11-15 2009-09-01 Discovery Laboratories, Inc. Methods to produce lung surfactant formulations via lyophilization and formulations and uses thereof
CA2584430A1 (en) 2004-12-01 2006-06-08 Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag Methods for preparing pimecrolimus
JP2009501206A (ja) * 2005-07-14 2009-01-15 ファイザー・プロダクツ・インク 非晶質アジスロマイシン粒子の生成方法
WO2007067566A2 (en) * 2005-12-07 2007-06-14 Wyeth Methods for preparing crystalline rapamycin and for measuring crystallinity of rapamycin compounds using differential scanning calorimetry
UA102128C2 (en) * 2008-12-05 2013-06-10 Х. Луннбек А/С Nalmefene hydrochloride dihydrate
WO2011015219A1 (en) 2009-08-06 2011-02-10 Shifa Pharmed Industrial Group Co. Process for the purification of azithromycin by separation from its thermal degradation products and/or isomers
CA2784494C (en) * 2009-12-18 2019-03-12 North-West University Composition comprising an amorphous non-crystalline glass form of roxithromycin
WO2013088274A1 (en) * 2011-12-14 2013-06-20 Wockhardt Limited Anhydrous amorphous azithromycin composition free of azithromycin dihydrate
CN106188177A (zh) * 2016-07-12 2016-12-07 浙江亚太药业股份有限公司 一种阿奇霉素化合物的制备方法及其药物制剂
CN108003109A (zh) * 2017-12-18 2018-05-08 南开大学 一种大环内酯化合物的晶型及其制备方法与用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI8110592A8 (en) * 1981-03-06 1996-06-30 Pliva Pharm & Chem Works Process for preparing of n-methyl-11-aza-10-deoxo-10-dihydroerythromycine a and derivatives thereof
US4474768A (en) 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
WO1989000576A1 (en) * 1987-07-09 1989-01-26 Pfizer Inc. Azithromycin dihydrate
US5686587A (en) 1993-05-19 1997-11-11 Pfizer Inc. Intermediate for azithromycin
ECSP951389A (es) 1995-02-21 1996-05-10 Un procedimiento de obtencion de hidrato de azitromicina
ES2122905B1 (es) 1996-07-11 1999-11-16 Astur Pharma Sa Sintesis de 11,12-hidrogenoortoborato de 9-desoxo-9a-aza-11,12-desoxi-9a-metil-9a-homoeritromicina a. un procedimiento para la preparacion de 9-desoxo-9a-aza-9a-metil-9a-homoeritromicina a dihidrato (azitromicina dihidrato).
PT102130A (pt) 1998-03-13 1999-09-30 Hovione Sociedade Quimica S A Processo de preparacao de dihidrato de azitromicina
TW546302B (en) * 1998-05-08 2003-08-11 Biochemie Sa Improvements in macrolide production
CA2245398C (en) * 1998-08-21 2002-01-29 Apotex Inc. Azithromycin monohydrate isopropanol clathrate and methods for the manufacture thereof

Also Published As

Publication number Publication date
ATE243704T1 (de) 2003-07-15
EP1103558A3 (en) 2001-07-04
EP1234833A3 (en) 2003-03-12
PL344101A1 (en) 2001-06-04
JP4260354B2 (ja) 2009-04-30
JP2009007376A (ja) 2009-01-15
DE60003509D1 (de) 2003-07-31
ATE325805T1 (de) 2006-06-15
EP1103558A2 (en) 2001-05-30
EP1234833B1 (en) 2006-05-10
ES2177373A1 (es) 2002-12-01
US6451990B1 (en) 2002-09-17
PL195910B1 (pl) 2007-11-30
TR200003474A2 (tr) 2001-07-23
TR200003474A3 (tr) 2001-07-23
ES2207403B1 (es) 2005-03-01
EP1103558B1 (en) 2003-06-25
DE60027919D1 (de) 2006-06-14
JP2001187797A (ja) 2001-07-10
DE60003509T2 (de) 2004-04-15
EP1234833A2 (en) 2002-08-28
ES2207403A1 (es) 2004-05-16
CA2326930A1 (en) 2001-05-26
CA2326930C (en) 2005-03-22

Similar Documents

Publication Publication Date Title
ES2177373B1 (es) Preparacion de azitromicina en su forma no cristalina
NL300305I1 (nl) Werkwijze voor de bereiding van gesubstitueerde octanoylamides.
DE60228184D1 (de) Verfahren zur Herstellung von Chondroitinsulfaten aus K4-Polysaccharid und so hergestellte Produkte
BR0313226B1 (pt) processo para produÇço de produto de fermentaÇço.
IT1317716B1 (it) Processo per la preparazione di perfluoropoliossialchileni conterminali ossidrilici.
FR2832063B1 (fr) Procede de production de solutions stables de substances phenoliques et les solutions en resultant
EP1182451A4 (en) BIOSENSOR AND METHOD FOR THE PRODUCTION THEREOF
HN2008001059A (es) Proceso de manufactura de un contenedor de papel p plastico con aislamiento de calor, preservacion de calor y producto por el mismo
DE60107833D1 (de) Veresterte polysaccharidprodukte, beta-lacton ringgeöffnete ketendimer-produkte enthaltende zusammensetzungen und verfahren zur deren herstellung
FR2813316B1 (fr) Procede de fabrication de bandes tres minces en alliage aluminium-fer
EP1375461A4 (en) DIPHENOL AND METHOD FOR THE PRODUCTION THEREOF
ES2066443T5 (es) Procedimiento para la obtencion de glicerinetersulfatos.
EP1437337A4 (en) 1,3-BUTYLENE GLYCOL AND METHOD FOR THE PRODUCTION THEREOF
EE05308B1 (et) Sulfoonamiid-asendatud imidasotriasinoonide valmistamismeetod
IT1319643B1 (it) Procedimento per la produzione di schiume poliuretaniche rigide edarticoli finiti da esse ottenuti.
AR028078A1 (es) Proceso para la produccion de grrnulos de enzimas
DK1429795T3 (da) Fremgangsmåde til fremstilling af ekstrakter af Pelargonium sidoides og/eller Pelargonium reniforme
EP1285961A4 (en) METHOD OF CREATING SWIVELING SPECIFIC PANCREATIC SPECIES IN VITRO
ATA8672000A (de) Verfahren zur herstellung von glasfliesen, glasbordüren, glasdekorpaneelen oder dgl.
AR033022A1 (es) Genes biosinteticos para la produccion de insecticida de butenilespinosina
AR036886A1 (es) Proceso para preparar un elemento en forma de gel y dispositivo para purificar el aire.
PT1702519E (pt) Processo para esterilização e produção de produto de pasta de peixe com uso de microbolhas e produto de pasta de peixe esterilizado obtido através do processo
FR2813010B1 (fr) Procede de fabrication d'un extrait d'argrumes riche en pectine, et extrait obtenu par ce procede
FR2823739B1 (fr) Procede de fabrication de nanostructures unidimensionnelles et nanostructures obtenues par ce procede
DE602005024679D1 (de) Verfahren zur herstellung von iminostilbenderivaten

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 20021201

Kind code of ref document: A1

FG2A Definitive protection

Ref document number: 2177373B1

Country of ref document: ES

FD2A Announcement of lapse in spain

Effective date: 20190521

FD2A Announcement of lapse in spain

Effective date: 20190604